Clinical review: Intrapericardial fibrinolysis in management of purulent pericarditis

Critical Care

Volumn 15, Issue 2, 2011, Pages

  Augustin, Pascal ^a   Desmard, Mathieu ^a   Mordant, Pierre ^a   Lasocki, Sigismond ^a   Maury, Jean Michel ^a   Heming, Nicholas ^a   Montravers, Philippe ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOLYTIC AGENT;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FIBRINOLYSIS; FOLLOW UP; HUMAN; MORBIDITY; PATHOPHYSIOLOGY; PERICARDIECTOMY; PERICARDIOCENTESIS; PERICARDITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PURULENT PERICARDITIS; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; ANIMAL; BLOOD; DISEASE MANAGEMENT; METHODOLOGY; PERICARDIAL EFFUSION; PHYSIOLOGY; RETROSPECTIVE STUDY; WOUND DRAINAGE;

ANIMALS; DISEASE MANAGEMENT; DRAINAGE; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; PERICARDIAL EFFUSION; PERICARDITIS; RETROSPECTIVE STUDIES;

EID: 84859920098     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10022     Document Type: Review

References (52)

1. Klacsmann PG, Bulkley BH, Hutchins GM. The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients. Am J Med 1977, 63:666-673. 10.1016/0002-9343(77)90150-4, 930941.
2. Parikh SV, Memon N, Echols M, Shah J, McGuire DK, Keeley EC. Purulent pericarditis, report of 2 cases and review of the literature. Medicine 2009, 88:52-65. 10.1097/MD.0b013e318194432b, 19352300.
3. Cui HB, Chen XY, Cui CC, Shou XL, Liu XH, Yao XW, Wang JK, Guan GC. Prevention of pericardial constriction by transcatheter intrapericardial fibrinolysis with urokinase. Chin Med Sci J 2005, 20:5-10.
4. Rubin RH, Moellering RC. Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am J Med 1975, 59:68-78. 10.1016/0002-9343(75)90323-X, 1138554.
5. Branch CF. Pathology of pericarditis. N Engl J Med 1933, 208:771-788.
6. Donnelly LF, Klosterman LA. The yield of CT of children who have complicated pneumonia and non-contributory chest radiography. AJR Am J Roentgenol 1998, 170:1627-1631.
7. Tan Kendrick AP, Ling H, Subramaniam R, Joseph VT. The value of early CT in complicated childhood pneumonia. Pediatr Radiol 2002, 32:16-21. 10.1007/s00247-001-0583-5, 11819056.
8. Kauffman CA, Watanakunakorn C, Phair JP. Purulent pneumococcal pericarditis. A continuing problem in the antibiotic era. Am J Med 1973, 54:743-750. 10.1016/0002-9343(73)90061-2, 4200204.
9. Arsura EL, Kilgore WB, Strategos E. Purulent pericarditis misdiagnosed as septic shock. South Med J 1999, 92:285-288. 10.1097/00007611-199903000-00005, 10094268.
10. Sagrista-Sauleda J, Barrabes JA, Permanyer-Miralda G, Soler-Soler J. Purulent pericarditis: review of a 20-year experience in a general hospital. J Am Coll Cardiol 1993, 22:1661-1665. 10.1016/0735-1097(93)90592-O, 8227835.
11. Gaudelus J, Leraillez J, Dandine M, Nathanson M, Perelman R. Péricardite purulente d'évolution constrictive subaiguë. A propos d'un cas. Revue de la littérature. Sem Hop 1983, 59:1527-1532.
12. Wright LT. Use of streptokinase-dornase in certain surgical conditions. J Int Coll Surg 1951, 15:286-298.
13. Bennett EV. Purulent pericarditis. J Thorac Cardiovasc Surg 1984, 87:641-642.
14. Adie GC, Childress WG. Experiences with streptokinase and streptodornase. Ann Surg 1951, 134:659-671. 1802973, 14878378.
15. Lundstrom R. Purulent pericarditis and empyema caused by Hemophilus influenzae, type B. Am Heart J 1955, 49:108-115. 10.1016/0002-8703(55)90060-0, 13218011.
16. Winkler WB, Karnik R, Slany J. Treatment of exudative fibrinous pericarditis with intrapericardial urokinase. Lancet 1994, 344:1541-1542. 10.1016/S0140-6736(94)90352-2, 7983956.
17. Schweitzer RJ. Purulent pericarditis; management with surgical drainage and enzymatic debridement. Am J Surg 1956, 91:906-910. 10.1016/0002-9610(56)90318-X, 13313897.
18. Mohammed KA, Nasreen N, Hardwick J, Logie CS, Patterson CE, Antony VB. Bacterial induction of pleural mesothelial monolayer barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001, 281:L119-125.
19. Rahman NM, Gleeson FV. New directions in the treatment of infected pleural effusions. Clin Radiol 2006, 61:719-722. 10.1016/j.crad.2006.05.004, 16905378.
20. Leak LV, Ferrans VJ, Cohen SR, Eidbo EE, Jones M. Animal model of acute pericarditis and its progression to pericardial fibrosis and adhesions: ultrastructural studies. Am J Anat 1987, 180:373-390. 10.1002/aja.1001800408, 3425565.
21. Pan HL, Liu J, Zhang YD. Effect of intrapericardial administration of urokinase on experimental constrictive pericarditis [abstract]. J Am Coll Cardiol 1994, 23(Suppl 1):46A.
22. Brook I, Frazier EH. Microbiology of acute purulent pericarditis. A 12-year experience in a military hospital. Arch Intern Med 1996, 156:1857-1860. 10.1001/archinte.156.16.1857, 8790081.
23. Brook I. Pericarditis due to anaerobic bacteria. Cardiology 2002, 97:55-58. 10.1159/000057672, 11978949.
24. Davies CWH, Gleeson FV, Davies RJO, . on behalf of BTS Pleural Disease Group, subgroup of the BTS Standards of Care Committee BTS guidelines for the management of pleural infection. Thorax 2003, 58(Suppl 2):18-28. on behalf of BTS Pleural Disease Group, subgroup of the BTS Standards of Care Committee.
25. Majid AA, Omar A. Diagnosis and management of purulent pericarditis. Experience with pericardiectomy. J Thorac Cardiovasc Surg 1991, 102:413-417.
26. Maisch B. Guidelines on the diagnosis and management of pericardial diseases - executive summary. Eur Heart J 2004, 25:587-610. 10.1016/j.ehj.2004.02.002, 15120056.
27. Sethi GK, Nelson RM, Jenson CB. Surgical management of acute septic pericarditis. Chest 1973, 63:732-735. 10.1378/chest.63.5.732, 4703627.
28. Ustunsoy H, Celkan MA, Sivrikoz MC, Kazaz H, Kilinc M. Intrapericardial fibrinolytic therapy in purulent pericarditis. Eur J Cardiothorac Surg 2002, 22:373-376. 10.1016/S1010-7940(02)00258-0, 12204726.
29. Corachan M, Poore P, Hadley GP, Tanner A. Purulent pericarditis in Papua New Guinea: report of 12 cases and review of the literature in a tropical environment. Trans R Soc Trop Med Hyg 1983, 77:341-343. 10.1016/0035-9203(83)90160-8, 6623591.
30. McCaughan BC, Schaff HV, Piehler JM, Danielson GK, Orszulak TA, Puga FJ, Pluth JR, Connolly DC, McGoon DC. Early and late results of pericardiectomy for constrictive pericarditis. J Thorac Cardiovasc Surg 1985, 89:340-350.
31. Bertog SC, Thambidorai SK, Parakh K, Schoenhagen P, Ozduran V, Houghtaling PL, Blackstone EH, Lauer MS, Klein AL. Constrictive pericarditis: etiology and cause specific survival after pericardiectomy. J Am Coll Cardiol 2004, 43:1445-1452. 10.1016/j.jacc.2003.11.048, 15093882.
32. DeValeria PA, Baumgartner WA, Casale AS, Greene PS, Cameron DE, Gott VL, Watkins L, Reitz BA. Current indications, risks, and outcome after pericardiectomy. Ann Thorac Surg 1991, 52:219-224. 10.1016/0003-4975(91)91339-W, 1863142.
33. Diacon AH, Theron J, Schuurmans MM, Van de Wall BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004, 170:49-53. 10.1164/rccm.200312-1740OC, 15044206.
34. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev 2008, 16:CD002312.
35. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ, . First Multicenter Intrapleural Sepsis Trial (MIST1) Group U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005, 352:865-874. 10.1056/NEJMoa042473, 15745977, First Multicenter Intrapleural Sepsis Trial (MIST1) Group.
36. Mann-Segal DD, Shanahan EA, Jones B, Ramasamy D. Purulent pericarditis: rediscovery of an old remedy. J Thorac Cardiovasc Surg 1996, 111:487-488. 10.1016/S0022-5223(96)70462-2, 8583826.
37. Defouilloy C, Meyer G, Slama M, Galy C, Verhaeghe P, Touati G, Ossart M. Intrapericardial fibrinolysis: a useful treatment in the management of purulent pericarditis. Intensive Care Med 1997, 23:117-118. 10.1007/s001340050301, 9037651.
38. Maynar J, Corral E, Manzano A, Fonseca F, Ulibarrena MA, Cantabrana S, Labayen F. Intrapericardial streptokinase fibrinolysis in the management of purulent pneumococcal pericarditis. Intensive Care Med 1997, 23:925-926.
39. Juneja R, Kothari SS, Saxena A, Sharma R, Johi A. Intrapericardial streptokinase in purulent pericarditis. Arch Dis Child 1999, 80:275-277. 10.1136/adc.80.3.275, 1717856, 10325712.
40. Bridgman PG. Failure of intrapericardial streptokinase in purulent pericarditis [letter]. Intensive Care Med 2001, 27:942. 10.1007/s001340100918, 11430559.
41. Schafer M, Lepori M, Delabays A, Ruchat P, Schaller MD, Broccard AF. Intrapericardial urokinase irrigation and systemic corticosteroids: an alternative to pericardectomy for persistent fibrino-purulent pericarditis. Cardiovasc Surg 2002, 10:508-511. 10.1016/S0967-2109(02)00067-4, 12379412.
42. Keersmaekers T, Elshot SR, Sergeant PT. Primary bacterial pericarditis. Acta Cardiol 2002, 57:387-389. 10.2143/AC.57.5.2005459, 12405580.
43. Cakir O, Gurkan F, Balci AE, Eren M, Dikici B. Purulent pericarditis in childhood: ten years of experience. J Pediatr Surg 2002, 37:1404-1408. 10.1053/jpsu.2002.35401, 12378443.
44. Reznikoff CP, Fish JT, Coursin DB. Pericardial infusion of tissue plasminogen activator in fibropurulent pericarditis. J Intensive Care Med 2003, 18:47-51. 10.1177/0885066602239124, 15189667.
45. Kamimura M, Suzuki T, Kudo K. Intrapericardial infusion of urokinase for the treatment of purulent pericarditis. Intern Med 2002, 41:412-413. 10.2169/internalmedicine.41.412, 12058895.
46. Tomkowski WZ, Gralec R, Kuca P, Burakowski J, Caban P, Orlowski T, Kurzyna M. Effectiveness of intrapericardial administration of streptokinase in purulent pericarditis. Herz 2004, 29:802-805. 10.1007/s00059-004-2655-4, 15599678.
47. Ekim H, Demirbaǧ R. Intrapericardial streptokinase for purulent pericarditis. Surg Today 2004, 34:569-572. 10.1007/s00595-004-2773-x, 15221548.
48. Bigham MT, Brady PW, Manning PB, Jacobs BR, Kimball TR, Wong HR. Therapeutic application of intrapericardial tissue plasminogen activator in a 4-month-old child with complex fibropurulent pericarditis. Pediatr Crit Care Med 2008, 9:e1-e4. 10.1097/01.PCC.0000298765.02358.07, 18477903.
49. Clase CM, Crowther MA, Ingram AJ, Cinà CS. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review. J Thromb Thrombolysis 2001, 11:127-136. 10.1023/A:1011272632286, 11406727.
50. Tsang TS, Califf RM, Stebbins AL, Lee KL, Cho S, Ross AM, Armstrong PW. Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Am J Cardiol 1997, 79:1232-1235. 10.1016/S0002-9149(97)00087-8, 9164891.
51. Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006, 3:75-80. 10.1513/pats.200510-113JH, 16493154.
52. Refsum H, Jonemann M, Lipton MJ, Skiolbebrand C, Carlsson E, Tyberg JV. Ventricular diastolic pressure-volume relations and the pericardium. Effects of changes in blood volume and pericardial effusion in dogs. Circulation 1981, 64:997-1004.